Echo Therapeutics (ECTE) Reports Q2 Loss of $0.82/Share
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.82), versus ($0.97) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agree Realty (ADC) Tops Q3 FFO by 4c
- NBT Bancorp (NBTB) Reports Q3 EPS of $0.46
- Compass Minerals (CMP) Misses Q3 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!